全文获取类型
收费全文 | 262447篇 |
免费 | 11551篇 |
国内免费 | 618篇 |
专业分类
耳鼻咽喉 | 3627篇 |
儿科学 | 7840篇 |
妇产科学 | 6930篇 |
基础医学 | 37903篇 |
口腔科学 | 8380篇 |
临床医学 | 16475篇 |
内科学 | 58063篇 |
皮肤病学 | 7929篇 |
神经病学 | 21493篇 |
特种医学 | 6521篇 |
外国民族医学 | 31篇 |
外科学 | 31282篇 |
综合类 | 1279篇 |
一般理论 | 51篇 |
预防医学 | 28557篇 |
眼科学 | 6408篇 |
药学 | 20035篇 |
中国医学 | 946篇 |
肿瘤学 | 10866篇 |
出版年
2023年 | 1336篇 |
2022年 | 1786篇 |
2021年 | 4753篇 |
2020年 | 2626篇 |
2019年 | 4868篇 |
2018年 | 7415篇 |
2017年 | 4732篇 |
2016年 | 4797篇 |
2015年 | 5350篇 |
2014年 | 6569篇 |
2013年 | 9853篇 |
2012年 | 15499篇 |
2011年 | 16122篇 |
2010年 | 8551篇 |
2009年 | 6877篇 |
2008年 | 13255篇 |
2007年 | 14045篇 |
2006年 | 13655篇 |
2005年 | 13302篇 |
2004年 | 12393篇 |
2003年 | 11536篇 |
2002年 | 11129篇 |
2001年 | 8128篇 |
2000年 | 8686篇 |
1999年 | 7012篇 |
1998年 | 1667篇 |
1997年 | 1164篇 |
1992年 | 3715篇 |
1991年 | 3458篇 |
1990年 | 3363篇 |
1989年 | 2944篇 |
1988年 | 2739篇 |
1987年 | 2586篇 |
1986年 | 2568篇 |
1985年 | 2372篇 |
1984年 | 1760篇 |
1983年 | 1522篇 |
1979年 | 1926篇 |
1978年 | 1268篇 |
1977年 | 1155篇 |
1975年 | 1367篇 |
1974年 | 1778篇 |
1973年 | 1752篇 |
1972年 | 1624篇 |
1971年 | 1552篇 |
1970年 | 1543篇 |
1969年 | 1580篇 |
1968年 | 1578篇 |
1967年 | 1404篇 |
1966年 | 1256篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Del Lama Rafael Silva Candido Raquel Mariana Chiari-Correia Natália Santana Nogueira-Barbosa Marcello Henrique de Azevedo-Marques Paulo Mazzoncini Tinós Renato 《Journal of digital imaging》2022,35(3):446-458
Journal of Digital Imaging - Vertebral Compression Fracture (VCF) occurs when the vertebral body partially collapses under the action of compressive forces. Non-traumatic VCFs can be secondary to... 相似文献
62.
63.
Tormo Nuria Giménez Estela Martínez-Navarro María Albert Eliseo Navalpotro David Torres Ignacio Gimeno Concepción Navarro David 《European journal of clinical microbiology & infectious diseases》2022,41(4):657-662
European Journal of Clinical Microbiology & Infectious Diseases - We compared the performance of an in-house-developed flow cytometry assay for intracellular cytokine staining (FC-ICS) and a... 相似文献
64.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献65.
66.
67.
A. Hochsprung S. Escudero-Uribe A.J. Ibáñez-Vera G. Izquierdo-Ayuso 《Neurología (Barcelona, Spain)》2021,36(6):433-439
IntroductionPain is highly prevalent in patients with multiple sclerosis (MS); it is chronic in 50% of cases and is classified as nociceptive, neuropathic, or mixed-type. Pain affects quality of life, sleep, and the activities of daily living. Electrotherapy is an interesting alternative or complementary treatment in the management of pain in MS, with new innovations constantly appearing.Material and methodsThis study evaluates the effectiveness of treatment with monopolar dielectric transmission of pulsed electromagnetic fields (PEMF) for pain associated with MS. We performed a randomised, placebo-controlled clinical trial including 24 patients, who were assessed with the Brief Pain Inventory, the Multiple Sclerosis International Quality of Life questionnaire, the Beck Depression Inventory, and the Modified Fatigue Impact Scale.ResultsStatistically significant improvements were observed in maximum and mean pain scores, as well as in the impact of pain on work, personal relationships, and sleep and rest. Not significant differences were found between the treatment and placebo groups.ConclusionsTreatment with PEMF may be effective in reducing pain in patients with MS, although further research is necessary to confirm its effectiveness over placebo and to differentiate which type of pain may be more susceptible to this treatment. 相似文献
68.
69.
70.
Yolanda Carrascal PhD Gregorio Laguna PhD Miriam Blanco MD Bárbara Segura MD Iciar Martínez-Almeida MD 《Journal of cardiac surgery》2020,35(2):457-459
Gray platelet syndrome (GPS) is a rare (<1/1 000 000) and inherited platelet function disorder characterized by macrothrombocytopenia, α-granule deficiency, and hemorrhages. Bleeding intensity does not correlate with platelet count nor with functional test results. We hereby describe the perioperative bleeding prevention and management of a patient with GPS requiring multiple redo cardiac surgeries. 相似文献